PROGRAF tacrolimus capsules and injection

The product information provided on Prograf.com is intended for residents of the United States.

ASTELLAS PHARMA US, INC.
WEBSITE TERMS OF USE.
All Rights Reserved.

ATTENTION: PLEASE READ THESE TERMS CAREFULLY BEFORE USING THIS WEBSITE. BY USING THIS WEBSITE, INCLUDING ANY SERVICES PROVIDED ON OR THROUGH THIS WEBSITE (www.prograf.com), YOU INDICATE THAT YOU ACCEPT THESE TERMS. IF YOU DO NOT ACCEPT THESE TERMS, DO NOT USE THIS SITE.

Astellas Pharma US, Inc., (Astellas) may at any time revise this Terms of Use Statement by updating this posting, so you should periodically examine the current Terms of Use to which you are bound. Certain provisions of these Terms of Use may be superseded by expressly designated legal notices or terms located on particular pages at this site. To the view the Terms of Use at any time go to www.astellas.com/us.

GENERAL INFORMATION
PRIVACY
SITE CONTENT
OBLIGATIONS OF SITE VISITORS OR USERS
LINKS TO OTHER WEBSITES
DISCLAIMER OF WARRANTIES
LIMITATION OF LIABILITY
THIS SITE IS INTENDED FOR US AUDIENCES ONLY

GENERAL INFORMATION

This site contains information about Astellas and its various products that may be of interest to Astellas customers, shareholders, and employees, as well as to members of the healthcare community and the general public. Please feel free to browse this website. Your access and use of the information herein are subject to the following terms and conditions, and all applicable laws. By accessing and browsing this website, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Astellas.

PRIVACY

Our policies concerning the use of your personal information are set forth in Astellas Internet Privacy Statement at www.astellas.com/us and incorporated by reference herein. By using this site or the services provided by or through this site (services), you agree to waive and release Astellas from any claim or liability in connection with the collection, use, or disclosure of information consistent with Astellas Internet Privacy Statement.

SITE CONTENT

All material on the site including, but not limited to, pictures, illustrations, designs, icons, text, audio clips, and video clips (collectively, the content) and all intellectual property rights therein, are owned, controlled, or licensed by Astellas or other individuals or organizations and are protected by worldwide copyright laws. You may use site content for your personal use for non-commercial purposes but no modification or further reproduction of content is permitted. The site content may not otherwise be copied, downloaded, reproduced, deleted, modified, republished, retransmitted, displayed, or used to create derivative works or performances without the express written permission of Astellas or the copyright owner. All other rights reserved.

Names, trademarks, service marks, trade names, trade dress, logos, and products of Astellas appearing on this site are protected in the United States and internationally and may not be used for advertising or publicity purposes, or to indicate any affiliation with or endorsement by Astellas, except with the express written permission of Astellas. Nothing contained herein shall be construed as conferring any license or right under any Astellas copyright. Other product, service and company names mentioned on the site are for identification purposes only and may be trademarks of their respective owners.

You are solely responsible for all the content including, but not limited to, text, photographs, caricatures, illustrations, designs, icons, articles, audio clips, and video clips (collectively, User Content) that you post, email, or otherwise transmit via this site. Astellas does not control User Content posted or otherwise transmitted via this site and Astellas does not guarantee the accuracy, integrity, or quality of such User Content. Any communications you send to this internet site or otherwise to Astellas by electronic mail, with the exception of personally identifiable information as defined in the Astellas Internet Privacy Policy, shall be deemed to be non-confidential and we shall have no obligation of any kind with respect to such information and shall be free to reproduce, use, disclose, and distribute the information to others without limitation. We shall be free to use any ideas, concepts, know-how or techniques contained in such information for any purpose whatsoever including but not limited to developing, manufacturing, and marketing products incorporating such information.

The content or material Astellas provides through the site is provided for informational purposes only and should not be construed as medical, legal, financial, investment, or other professional advice or opinion. We do not offer personalized medical advice or patient-specific treatment advice. Only your doctor or other healthcare professional can determine if a product described in this website is appropriate for you. Use of this site is not a substitute for a call or visit to, or consultation with, your physician or healthcare professional. You should not rely on the site or any other service offered by or through this site for medical diagnosis or treatment. YOU SHOULD NEVER DISREGARD OR DELAY SEEKING MEDICAL ADVICE BECAUSE OF SOMETHING THAT YOU HAVE SEEN ON THIS SITE. PLEASE CONSULT WITH YOUR DOCTOR, OR OTHER QUALIFIED HEALTHCARE PROFESSIONAL, BEFORE USING ANY OBLIGATIONS DISCUSSED ON THIS SITE.

OBLIGATIONS OF SITE VISITORS OR USERS

You agree not to do any of the following while visiting or using the site or any Services provided by or through this site:

Impersonate or misrepresent your affiliation with any person or entity;
Except as expressly permitted by the rules of this site, post or transmit any unsolicited advertising, promotional materials, (junk mail), (spam), (chain letters), or any other form of solicitation on the site or through the Services;
Post or transmit any information or material that is defamatory, offensive, indecent, obscene, or unlawful;
Post or transmit any information or software which contains a virus, Trojan horse, worm or other harmful components;
Violate any applicable law or regulation, including without limitation any local, state, provincial, national or international law, any export control laws, or any regulations promulgated by any state or federal authority;
Access or use password protected, secure or non-public areas of the site without authorization; or
Frame, repackage, or otherwise re-distribute any portion of the site.

Astellas may, at its sole discretion, take any action Astellas deems necessary, including, but not limited to, termination of access to the site, if Astellas believes a user's conduct or content fails to conform with these terms and conditions or may create liability for Astellas, its partners, its suppliers or other users. Astellas will not be liable to you or any third party as a result of such termination and modification. The terms and conditions provided in the Terms of Use will survive any such termination and modification.

LINKS TO OTHER WEBSITES

Astellas provides links on this site to other websites that are not maintained by or under the control of Astellas solely as a convenience to you. If you use these links, you will leave this site. Please remember that linked sites are not necessarily Astellas sites and the information could change without Astellas's Knowledge. Third party linked sites and their contents should not be attributed to Astellas (or any of its affiliated companies) in any manner. Astellas has not attempted to verify the truth or accuracy of any third party or content and does not make any representations or warranties about them. If you decide to access any of the third party sites linked to this site, you do so entirely at your own risk. In the event Astellas endorses a particular organization, we will clearly state our endorsement next to any link to that organization.

DISCLAIMER OF WARRANTIES

THIS SITE, INCLUDING any information, PRODUCTS, SERVICES, OR MATERIAL made available on OR THROUGH this site, IS PROVIDED ON AN (AS IS) AND (AS AVAILABLE) BASIS. TO THE MAXIMUM EXTENT PERMITTED BY LAW, ASTELLAS EXPRESSLY DISCLAIMS ALL WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT. Furthermore, Astellas does not warrant the accuracy of completeness of any information at this site and may make changes to the information at this site, including to the products, SERVICES, or prices described at this site, at any time without prior notice to users of this site. Information at this site that is periodically updated may not be current at the moment you visit this site and may contain errors. ASTELLAS MAKES NO WARRANTY THAT THE SITE WILL MEET YOUR REQUIREMENTS; THAT THE SITE WILL BE UNINTERRUPTED, TIMELY, SECURE, OR ERROR FREE; that messages or request will be delivered; that defects will be corrected; or that this site IS free of viruses or other harmful components. Astellas MAKES NO WARRANTY REGARDING ANY GOODS OR SERVICES PURCHASED OR OBTAINED THROUGH THE SITE OR ANY TRANSACTIONS ENTERED INTO THROUGH THE SITE. YOU ASSUME THE ENTIRE RISK AS TO THE RESULTS AND PERFORMANCE OF THE SITE AND ANY GOODS OR SERVICES PURCHASED THEREFROM.

LIMITATION OF LIABILITY

In no event will Astellas be liable for any damages whatsoever, including but not limited to direct, indirect, incidental, punitive, and consequential damages (including without limitation those resulting from lost profits, lost data or business interruption) arising out of the use, inability to use, or the result of use of this site, any websites linked to this site, the materials or information contained at any or all such sites, or the materials, products or services offered on this site or sites linked to this site, whether based on warranty, contact, tort or any other legal theory and whether or not advised on the possibility of such damages. In no event will ASTELLAS, its suppliers, or any other party involved in creating, producing, or delivering this site be liable to you in any manner whatsoever for any design made or action or non-action taken by you in reliance upon information provided through this site. Applicable law may not allow the exclusion or limitation of incidental or consequential damages so the above limitation or exclusion may not apply to you.

THIS SITE IS INTENDED FOR US AUDIENCES ONLY

Access to and use of this website is subject to the above terms and conditions. This website was developed and is maintained by Astellas Pharma US, Inc. Product information, copy and claims are intended only for the residents of the United States.

The information provided on this website is intended for residents of the United States

Indication

Prograf^® (tacrolimus) is indicated for the prophylaxis of organ rejection in patients receiving allogeneic liver, kidney, or heart transplants. It is recommended that Prograf be used concomitantly with adrenal corticosteroids. Because of the risk of anaphylaxis, Prograf injection should be reserved for patients unable to take Prograf capsules orally. In heart transplant recipients, it is recommended that Prograf be used in conjunction with azathioprine or mycophenolate mofetil. The safety and efficacy of the use of Prograf with sirolimus has not been established.

Important Safety Information

WARNING
Increased susceptibility to infection and the possible development of lymphoma may result from immunosuppression. Only physicians experienced in immunosuppressive therapy and management of organ transplant patients should prescribe Prograf. The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient.

Prograf is contraindicated in patients with a hypersensitivity to tacrolimus. Prograf injection is contraindicated in patients with a hypersensitivity to castor oil. Patients receiving Prograf injection should be under continuous observation for at least the first 30 minutes following the start of infusion and at frequent intervals thereafter. If signs or symptoms of anaphylaxis occur, the infusion should be stopped.
Insulin-dependent post-transplant diabetes mellitus was reported in 11% to 20% of Prograf-treated liver, kidney, and heart transplant patients with no prior history of diabetes mellitus. Black and Hispanic kidney transplant patients were at increased risk. Insulin dependence was reversible in 15% to 45% of patients at 1 year.
Prograf has been associated with nephrotoxicity, particularly when used in high doses. In particular, to avoid excess nephrotoxicity, Prograf should not be used simultaneously with cyclosporine. Prograf or cyclosporine should be discontinued at least 24 hours prior to initiating the other. In the presence of elevated Prograf or cyclosporine concentrations, dosing with the other drug usually should be further delayed. Use of Prograf with sirolimus in heart transplant patients in a US study was associated with increased risk of renal function impairment and is not recommended.
Mild to severe hyperkalemia was reported in 31% of kidney transplant recipients and in 45% and 13% of liver transplant recipients in the US and European randomized trials, respectively, and in 8% of heart transplant recipients in a European randomized trial and may require treatment. Serum potassium levels should be monitored and potassium-sparing diuretics should not be used during Prograf therapy (see PRECAUTIONS).
Neurotoxicity, including tremor, headache, and other changes in motor function, mental status, and sensory function were reported in approximately 55% of liver transplant recipients in the two randomized studies. Tremor occurred more often in Prograf-treated kidney transplant (54%) and heart transplant patients (15%) compared to cyclosporine-treated patients. Seizures have occurred in adult and pediatric patients receiving Prograf. Coma and delirium also have been associated with high plasma concentrations of tacrolimus.
The principal adverse reactions of Prograf include tremor, headache, hypertension, gastrointestinal disturbance, abnormal renal function, hyperglycemia, leukopenia, CMV infection, infection, and hyperlipemia.